Bavarian Nordic — Maj 2016
-
Nordea hæver target på Zealand fra 116 til 127. Fra sælge tilbage hold. "Lower Adcomm risk"
-
Jeg vil tro proceduren er ens.
-
Har ikke fantasi til at forstille mig at udfaldet for Sanofi/Zealand ikke bliver lige så positivt som Novos.
-
Det tror jeg også Novod mener. Derfor hans opjustering.
-
Danske om Zealand: : Given pos vote for Xultphy (NOVO NORDISK) we see LixiLan meeting today
is de-risked and expect shares higher. -
Min supplering på faldet sidder foreløbig lige i øjet. Med en positiv anbefaling ryger nok meget op i morgen.
-
Ja, hvis Novo kan stige 3,7 % på positiv anbefaling, hvad kan Zealand så ikke drive det til i morgen

-
Bavarian competitor
Novavax Inc: Respiratory vaccine gets fast track status Company says U.S. FDA has granted "fast track" status to its vaccine aimed at preventing infection with common type of respiratory virus in elderly patients
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind